{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:28:25Z","timestamp":1779233305695,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.path.2022.09.009","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T01:43:45Z","timestamp":1670550225000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Para This, Fibromin That"],"prefix":"10.1016","volume":"16","author":[{"given":"Emad","family":"Ababneh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vania","family":"Nos\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.path.2022.09.009_bib1","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.path.2022.09.009_bib2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid cancer: a review","volume":"11","author":"Machado","year":"2019","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.path.2022.09.009_bib3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.path.2022.09.009_bib4","series-title":"WHO classification of Tumours of endocrine organs","year":"2017"},{"issue":"1","key":"10.1016\/j.path.2022.09.009_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO Classification of Parathyroid Tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.09.009_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.09.009_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","article-title":"Negative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas","volume":"21","author":"Kruijff","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2022.09.009_bib8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2022.09.009_bib9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12022-020-09631-4","article-title":"Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing","volume":"31","author":"Turchini","year":"2020","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.09.009_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13244-016-0519-0","article-title":"Hyperparathyroidism jaw tumour syndrome: a pictoral review","volume":"7","author":"du Preez","year":"2016","journal-title":"Insights Imaging"},{"issue":"4","key":"10.1016\/j.path.2022.09.009_bib11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism\u2013jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.path.2022.09.009_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-09-0272","article-title":"Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism\u2013jaw tumor syndrome","volume":"17","author":"Panicker","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.path.2022.09.009_bib13","doi-asserted-by":"crossref","first-page":"e97994","DOI":"10.1371\/journal.pone.0097994","article-title":"Characterization of a New CDC73 Missense Mutation that Impairs Parafibromin Expression and Nucleolar Localization","volume":"9","author":"Masi","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.path.2022.09.009_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"18","key":"10.1016\/j.path.2022.09.009_bib15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and Germ-Line Mutations of the HRPT2 Gene in Sporadic Parathyroid Carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.path.2022.09.009_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","article-title":"CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer","volume":"2","author":"Cetani","year":"2013","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.path.2022.09.009_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","article-title":"Understanding the Genetic Basis of Parathyroid Carcinoma","volume":"25","author":"Gill","year":"2014","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.09.009_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.beem.2018.11.001","article-title":"Molecular pathogenesis of parathyroid tumours","volume":"32","author":"Cinque","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2022.09.009_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","article-title":"Loss of parafibromin expression in a subset of parathyroid adenomas","volume":"13","author":"Juhlin","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.path.2022.09.009_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cen.14161","article-title":"Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data","volume":"92","author":"Zhu","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.path.2022.09.009_bib21","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181778","article-title":"Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT","volume":"39","author":"Pyo","year":"2019","journal-title":"Biosci Rep"},{"issue":"3","key":"10.1016\/j.path.2022.09.009_bib22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","article-title":"Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis","volume":"54","author":"Hu","year":"2016","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.path.2022.09.009_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4158\/EP-2018-0538","article-title":"The Influence of Surgical Extent and Parafibromin Staining on The Outcome of Parathyroid Carcinoma: 20-Year Experience From a Single Institute","volume":"25","author":"Hu","year":"2019","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.path.2022.09.009_bib24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/modpathol.2010.236","article-title":"Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma","volume":"24","author":"Witteveen","year":"2011","journal-title":"Mod Pathol"},{"issue":"19","key":"10.1016\/j.path.2022.09.009_bib25","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.path.2022.09.009_bib26","doi-asserted-by":"crossref","first-page":"e45567","DOI":"10.1371\/journal.pone.0045567","article-title":"Novel HRPT2\/CDC73 Gene Mutations and Loss of Expression of Parafibromin in Chinese Patients with Clinically Sporadic Parathyroid Carcinomas","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.path.2022.09.009_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","article-title":"CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort","volume":"35","author":"Guarnieri","year":"2012","journal-title":"Cell Oncol"},{"issue":"3","key":"10.1016\/j.path.2022.09.009_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/PAP.0000000000000227","article-title":"New and Emerging Biomarkers in Endocrine Pathology","volume":"26","author":"Papathomas","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2022.09.009_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2017.05.010","article-title":"Alterations of DNA methylation in parathyroid tumors","volume":"469","author":"Guarnieri","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.path.2022.09.009_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1677\/ERC-09-0291","article-title":"CDC73\/HRPT2 CpG island hypermethylation and mutation of 5\u2032-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors","volume":"17","author":"Hahn","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.path.2022.09.009_bib31","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","article-title":"Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center","volume":"32","author":"Juhlin","year":"2019","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2022.09.009_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12022-019-09592-3","article-title":"Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms","volume":"30","author":"Silva-Figueroa","year":"2019","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.09.009_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00428-010-1032-3","article-title":"Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours","volume":"459","author":"Juhlin","year":"2011","journal-title":"Virchows Arch"},{"issue":"26","key":"10.1016\/j.path.2022.09.009_bib34","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","article-title":"Nucleolar localization of parafibromin is mediated by three nucleolar localization signals","volume":"581","author":"Hahn","year":"2007","journal-title":"FEBS Lett"},{"issue":"7","key":"10.1016\/j.path.2022.09.009_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A\u00a0nationwide study on parathyroid carcinoma","volume":"56","author":"Ryh\u00e4nen","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.path.2022.09.009_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1761030","article-title":"Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature","volume":"2019","author":"Torresan","year":"2019","journal-title":"Int J Endocrinol"},{"issue":"17","key":"10.1016\/j.path.2022.09.009_bib37","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJMcpc2107351","article-title":"Case 32-2021: A 14-Year-Old Girl with Swelling of the Jaw and Hypercalcemia","volume":"385","author":"Carpenter","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.path.2022.09.009_bib38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.path.2019.08.006","article-title":"Parathyroid Pathology","volume":"12","author":"Guilmette","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.path.2022.09.009_bib39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fendo.2019.00731","article-title":"The Clinicopathological Spectrum of Parathyroid Carcinoma","volume":"10","author":"Akirov","year":"2019","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.path.2022.09.009_bib40","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid Carcinoma: A 43-Year Outcome and Survival Analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.path.2022.09.009_bib41","doi-asserted-by":"crossref","first-page":"R441","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.path.2022.09.009_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","article-title":"Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations","volume":"143","author":"Sarquis","year":"2008","journal-title":"Surgery"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:26Z","timestamp":1761749006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918122000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1875918122000824"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2022.09.009","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Para This, Fibromin That","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2022.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}